Amyloid β The dominant search intent for "apoe peptide" is to understand the nature, function, and therapeutic potential of apoE mimetic peptides, particularly in the context of neurological disorders like Alzheimer's disease and brain injury.
Tier 1 Entities and Phrases:
* apoe peptide
* ApoE mimetic peptides
* Apolipoprotein E (ApoE)
* Alzheimer's disease (AD)
* brain injury
* therapeutic potential
* engineered fragments
* LDL-receptor binding site
* pre-clinical and clinical settings
* CNS disorders
Tier 2 Entities and Phrases:
* ApoE4 allele
* A\u03b2 (amyloid beta)
* lipid metabolism
* cholesterol transport
* inflammation
* neuroinflammation
* COG 133
* blocking peptide
* neural and vascular health
* immunomodulatory properties
* receptor-binding domain
* APP processing
* amyloid beta production
Tier 3 Entities and Phrases:
* Rs7412
* GeneCards
* ApoE R2/ApoE R2 Peptide (P1767)
* HDL mimetic peptides
* Herpes simplex virus type 1
* Rat APOE
---
ApoE peptides, specifically ApoE mimetic peptides, represent a promising frontier in therapeutic development, particularly for neurological conditions1天前—Increased amyloid beta-peptidedeposition in cerebral cortex as a consequence ofapolipoprotein Egenotype in late-onset Alzheimer disease.. These engineered fragments are derived from the vital Apolipoprotein E (ApoE) protein, a key player in lipid metabolism and transport within the body. The primary focus surrounding ApoE mimetic peptides is their potential to replicate the beneficial functions of native ApoE, especially its interaction with LDL receptors, to address complex diseases such as Alzheimer's disease and acute brain injury.This blocking peptide isdesigned to be used with its corresponding antibody. If the corresponding antibody is not noted on this datasheet then please ... Research indicates that these peptides show significant promise in pre-clinical and clinical settings for managing central nervous system (CNS) disorders.
Apolipoprotein E is a protein essential for transporting fats, including cholesterol and phospholipids, throughout the body. It circulates in various forms, with certain isoforms, notably the ApoE4 allele, being strongly associated with an increased genetic risk for late-onset Alzheimer's disease. This genetic link has spurred significant research into how ApoE functions and how its activity can be modulated therapeutically.作者：JN Buxbaum·2024·被引用次数：117—Onepeptidedrug, previously reported to create local iatrogenic amyloid deposits at its injection site, has been shown to induce rare ... ApoE mimetic peptides are designed to mimic specific functional domains of the native ApoE protein, often targeting its receptor-binding site. By doing so, they aim to harness ApoE's protective and reparative capabilities without necessarily administering the full protein, which can have complex interactions.作者：M Miyata·1996·被引用次数：1190—Theapolipoprotein E(APOE) E4 allele is associated with Alzheimer's disease, cardiovascular disease, and decreased longevity.
The therapeutic potential of ApoE mimetic peptides is being explored across a range of neurological conditions. In Alzheimer's disease, these peptides have demonstrated an ability to reduce amyloid beta (A\u03b2) production and deposition, a hallmark of the diseaseAPOEa secreted apolipoprotein that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids.. Furthermore, studies suggest that ApoE mimetics can significantly improve behavioral deficits, reduce neuroinflammation, and mitigate other pathological markers in animal models of Alzheimer's.作者：JN Buxbaum·2024·被引用次数：117—Onepeptidedrug, previously reported to create local iatrogenic amyloid deposits at its injection site, has been shown to induce rare ...
Beyond Alzheimer's, ApoE mimetic peptides are also showing promise in the context of acute brain injury, such as traumatic brain injury (TBI). ApoE itself has immunomodulatory properties that can help reduce secondary tissue damage following injury. Mimetic peptides derived from ApoE are being investigated for their capacity to cross the blood-brain barrier and exert similar protective effects, improving functional and histological outcomes in preclinical models.APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs. Their ability to reduce inflammation and oxidative stress positions them as potential broad-spectrum therapeutics for various CNS insults.
The design of ApoE mimetic peptides often centers on replicating the receptor-binding domain of ApoE, which interacts with low-density lipoprotein (LDL) receptors and other related receptors. For instance, peptides like COG 133 are fragments engineered to compete with the full ApoE protein for receptor binding, thereby modulating cellular responses作者：JR Lynch·2003·被引用次数：494—Our results suggest that endogenousapoEplays an important role in modifying both systemic and brain inflammatory responses.. Some ApoE-derived peptides specifically target the receptor-binding domain (e.作者：JN Buxbaum·2024·被引用次数：117—Onepeptidedrug, previously reported to create local iatrogenic amyloid deposits at its injection site, has been shown to induce rare ...g., LRKLRKRLL sequence) and have been found to reduce inflammation and influence amyloid precursor protein (APP) processing.
These peptides are not only being investigated for their direct therapeutic effects but also as tools in research. For example, specific ApoE blocking peptides are designed for use with corresponding antibodies to study ApoE interactions and functions in laboratory settings. The development of these peptides represents a sophisticated approach to drug design, aiming to achieve targeted therapeutic benefits by mimicking the essential functional elements of a complex endogenous protein作者：FL Vecchio·2022·被引用次数：28—Human apolipoprotein E (ApoE) is a 299-amino acid secreted glycoprotein that binds cholesterol and phospholipids. ApoE exists as three ....
While the research into ApoE peptides is highly encouraging, translating these findings into widely available treatments involves significant challenges. Further clinical trials are necessary to establish safety and efficacy in human patients.HDL, ApoA-I and ApoE-Mimetic Peptides: Potential Broad ... Understanding the precise mechanisms by which different ApoE mimetic peptides exert their effects, optimizing their delivery, and managing potential off-target interactions are critical areas of ongoing research. Nevertheless, the continued investigation into ApoE mimetic peptides underscores their potential as a novel class of therapeutics for some of the most challenging neurological and neurodegenerative diseases.Apolipoprotein E Receptor 2 (ApoER2), also known as LRP8,is a Low-density lipoprotein receptor family memberinvolved in endocytosis and signal ...
Join the newsletter to receive news, updates, new products and freebies in your inbox.